McManus Matthew bought TECH
February 1, 2025 · Form 4 insider transaction
McManus Matthew bought 4,620 shares of Bio-Techne Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,620
Price
$0.00
Total value
N/A
InsiderMcManus Matthew
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 1, 2025
Filing dateFebruary 4, 2025
Shares owned after4,620
OwnershipDirect
10b5-1 planNo
AmendedNo